Infliximab biosimilar CT-P13 in Crohn’s disease.

Related Articles

Infliximab biosimilar CT-P13 in Crohn’s disease.

Lancet. 2019 Mar 28;:

Authors: Gecse KB, D’Haens GR

PMID: 30929894 [PubMed – as supplied by publisher]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/30929894?dopt=Abstract